Immediate Impact
2 by Nobel laureates 5 from Science/Nature 106 standout
Citing Papers
Biomarker Changes during 20 Years Preceding Alzheimer’s Disease
2024 Standout
Innate immune activation in neurodegenerative diseases
2024 Standout
Works of Luiza Spiru being referenced
Masitinib for mild-to-moderate Alzheimer’s disease: results from a randomized, placebo-controlled, phase 3, clinical trial
2023
Prevalence and prognostic value of CSF markers of Alzheimer's disease pathology in patients with subjective cognitive impairment or mild cognitive impairment in the DESCRIPA study: a prospective cohort study
2009
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Luiza Spiru | 421 | 419 | 9 | 137 | 21 | 659 | |
| Karen C. Holdridge | 443 | 401 | 5 | 108 | 29 | 748 | |
| Andrew P. Keegan | 324 | 220 | 3 | 208 | 26 | 834 | |
| Agustin Yip | 262 | 220 | 3 | 135 | 28 | 751 | |
| Jeanette Günther | 358 | 228 | 3 | 123 | 14 | 596 | |
| Elizabeth Herries | 323 | 547 | 123 | 15 | 753 | ||
| Maria L. Zorzitto | 363 | 358 | 4 | 121 | 21 | 781 | |
| Hyo Jung Choi | 313 | 272 | 6 | 153 | 40 | 678 | |
| Elisa de Paula França Resende | 304 | 253 | 4 | 185 | 31 | 639 | |
| Jeffrey Sevigny | 251 | 342 | 131 | 16 | 846 | ||
| Katarzyna Adamczuk | 293 | 315 | 220 | 29 | 620 |
All Works
Login with ORCID to disown or claim papers
Loading papers...